Events
This was 1 year ago
Metz, France
Horizon Europe Cluster 6 & Missions - Conference & Bilateral/B2B meetings
To pave the way for future Horizon Europe Cluster 6 & EU Missions calls 2025, Enterprise Europe Network (EEN) of Grand Est Développement (Grand E-Nov+) in close partnership with cross-border National Contact Points (NCPs) Networks and EEN from Wallonia and Luxembourg, we prepared this unique Matchmaking event:
For more information and to register for this event, please access its dedicated page via this link.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
The ERC is inviting expressions of interest from current ERC grantees for a one-day science communication training taking place in Brussels. Interested ERC grantees are invited to complete the online expression of interest form. The deadline for applications is 24 August 2026 12 pm CEST. Notification of selected participants (approximately 40) is...
Read moreThe project VALLEYS aims to strengthen knowledge valorisation in Europe by building a network of knowledge valorisation intermediaries connecting more than 150 organisations from over 25 countries, empowering organisations such as TTOs, incubators, science parks, clusters, and citizen engagement entities to adopt and scale the EU Guiding Principles...
Read moreEIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...
Read moreThis one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
